Cite
HARVARD Citation
Huang, J. et al. (2018). Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma. Bone marrow transplantation. pp. 701-707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Huang, J. et al. (2018). Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma. Bone marrow transplantation. pp. 701-707. [Online].